Ethan M Shevach

14PUBLICATIONS
103CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 25, 2026
Antibody Blockade of Ly49/MHC-I interactions enhances Innate and Adaptive Immunity Against Cancer Metastasis.

|Feb 02, 2026
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.

Jiansheng Jiang, Abir K Panda, Kannan Natarajan

|Oct 01, 2025
Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity.

Abir K Panda, Kannan Natarajan, Surajit Sinha

|Sep 30, 2025
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth.

Surajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves

|Apr 29, 2024
Polyclonally Derived Alloantigen-Specific T Regulatory Cells Exhibit Target-Specific Suppression and Capture MHC Class II from Dendritic Cells.

Yoshihiro Oya, Yasuyo Tanaka, Takuya Nakazawa

|Sep 27, 2023
Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability.

M Edward Medof, Sadiye A Rieder, Ethan M Shevach

Pageof 3

Frequent Collaborators

5 joint publications

Abir Kumar Panda

4 joint publications

Kannan Natarajan

4 joint publications

David H Margulies

3 joint publications

Sruthi Chempati